Acetylcholinesterase, a key prognostic predictor for hepatocellular carcinoma, suppresses cell growth and induces chemosensitization
暂无分享,去创建一个
Ming Yao | Tao Wang | Jinjun Li | Jia Fan | Yingjun Zhao | Xianghuo He | Qiang Gao | Jianren Gu | Jianren Gu | Xianghuo He | Q. Gao | Xin Hu | Jinjun Li | M. Yao | Jia Fan | D. Wan | Xiaoying Wang | Yingjun Zhao | Tao-yang Chen | Mingxia Yan | Taoyang Chen | Dafang Wan | Xin Hu | Tao Wang | Xin Hui | M. Yan | Xiaoying Wang | Xin Hui | J. Gu | Ming-xia Yan
[1] H. Soreq,et al. A role for cholinesterases in tumorigenesis? , 1991, Cancer cells.
[2] C. Kirkpatrick,et al. Acetylcholine beyond neurons: the non‐neuronal cholinergic system in humans , 2008, British journal of pharmacology.
[3] S. Moore,et al. Identification of a structural site on acetylcholinesterase that promotes neurite outgrowth and binds laminin-1 and collagen IV. , 2004, Biochemical and biophysical research communications.
[4] B. Evers,et al. Regulation of TRAIL Expression by the Phosphatidylinositol 3-Kinase/Akt/GSK-3 Pathway in Human Colon Cancer Cells* , 2002, The Journal of Biological Chemistry.
[5] S. Greenfield,et al. Effects of acetylcholinesterase and butyrylcholinesterase on cell survival, neurite outgrowth, and voltage-dependent calcium currents of embryonic ventral mesencephalic neurons , 2003, Experimental Neurology.
[6] S. Brimijoin,et al. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex , 2003, Neurobiology of Aging.
[7] Jun Qin,et al. Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .
[8] Y. Hemo,et al. The stress-associated acetylcholinesterase variant AChE-R is expressed in human CD34(+) hematopoietic progenitors and its C-terminal peptide ARP promotes their proliferation. , 2002, Experimental hematology.
[9] Guangdou Zhou,et al. Regulation of acetylcholine receptor clustering by the tumor suppressor APC , 2003, Nature Neuroscience.
[10] H. Schuller. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.
[11] J. Hoek,et al. Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. , 2005, Cancer research.
[12] V. P. Whittaker. Identification of Acetylcholine and Related Esters of Biological Origin , 1963 .
[13] D. Auclair,et al. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis , 2004, Cancer Research.
[14] P. Layer. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease , 1996, Neurochemistry International.
[15] J. Sussman,et al. Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. , 2005, Current opinion in pharmacology.
[16] B. Weeks,et al. Agrin and laminin induce acetylcholine receptor clustering by convergent, Rho GTPase-dependent signaling pathways , 2007, Journal of Cell Science.
[17] Jian Yu,et al. Large-scale cDNA transfection screening for genes related to cancer development and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[18] G. Mufti,et al. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). , 1996, Leukemia research.
[19] Jun Qin,et al. Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.
[20] M. Valenzuela,et al. A rat mammary tumor model induced by the organophosphorous pesticides parathion and malathion, possibly through acetylcholinesterase inhibition. , 2001, Environmental health perspectives.
[21] N Tygstrup,et al. Prognostic Factors in Cirrhosis Identified by Cox's Regression Model , 2007, Hepatology.
[22] O. Rios,et al. Acetylcholinesterase and butyrylcholinesterase histochemical activities and tumor cell growth in several brain tumors. , 2001, Surgical neurology.
[23] H. El‐Serag,et al. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.
[24] C. Porta,et al. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] K. Kawashima,et al. Evolutional study on acetylcholine expression. , 2003, Life sciences.
[26] Jianren Gu,et al. Ciliary neurotrophic factor receptor α subunit–modulated multiple downstream signaling pathways in hepatic cancer cell lines and their biological implications , 2007, Hepatology.
[27] Zaira García,et al. Phosphoinositide 3‐kinase controls early and late events in mammalian cell division , 2006, The EMBO journal.